Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Mark W. Clemens(The University of Texas MD Anderson Cancer Center), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Jing Ning(The University of Texas MD Anderson Cancer Center), Ahmed Dogan(The University of Texas MD Anderson Cancer Center), Charles E. Butler(The University of Texas MD Anderson Cancer Center), Ken H. Young(Duke Medical Center), Judith A. Ferry(Harvard University), Kelly K. Hunt(The University of Texas MD Anderson Cancer Center), Elizabeth A. Morgan(Brigham and Women's Hospital), Dennis D. Weisenburger(University of Nebraska Medical Center), T.M. Williams(The University of Texas MD Anderson Cancer Center), Arianna Di Napoli(Azienda Ospedaliera Sant'Andrea), Colleen M. McCarthy(Memorial Sloan Kettering Cancer Center), Stephen Lade(The University of Texas MD Anderson Cancer Center), Yasuhiro Oki(Unknown), Loretta J. Nastoupil(The University of Texas MD Anderson Cancer Center), Nora Thormann, Jorge Piccolini(The University of Texas MD Anderson Cancer Center), Ruben Reyes(The University of Texas MD Anderson Cancer Center), Vinita Parkash(The University of Texas MD Anderson Cancer Center), Rashmi Kanagal‐Shamanna(The University of Texas MD Anderson Cancer Center), Neha Mehta–Shah(The University of Texas MD Anderson Cancer Center), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Michelle A. Fanale(Pfizer (United States)), Summer E. Hanson(The University of Texas MD Anderson Cancer Center), Aliyah R. Sohani(Massachusetts General Hospital), Jun Liu(Sichuan University), L. Jeffrey Medeiros(Delaware Division of Libraries), Hui Liu(Shanghai University), Rakesh Gaur(The University of Texas MD Anderson Cancer Center)
Journal of Clinical Oncology
December 2, 2015
Cited by 418


Related Papers